Intellia Therapeutics Inc (NASDAQ:NTLA)
| 43.05 BATS BZX Real-Time Price As of 1:13pm ET |  +1.78 / +4.31%Today’s Change | 32.44 Today|||52-Week Range 76.45 | +23.39% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -12.4M | -31.6M | -67.5M | -85.3M | |
| Depreciation | 328.0K | 1.1M | 3.0M | 4.5M | ||
| Total Other Cash Flow | 305.0K | 6.7M | 15.5M | 16.4M | ||
| Funds From Operations | -11.8M | -23.8M | -49.1M | -64.4M | ||
| Funds From/For Other Operating Expenses | -10.0M | -59.9M | 16.2M | -3.2M | ||
| Net Cash Flow - Operating Activities | -1.8M | 36.1M | -65.3M | -61.3M | ||
| Investing | Increase In Investments | 0.00 | -- | 0.00 | -254.6M | |
| Capital Expenditures | -2.6M | -6.2M | -10.1M | -6.4M | ||
| Fixed Asset Disposal | -- | -- | -- | 131.0K | ||
| Net Cash Flow Investing | -2.6M | -6.2M | -10.1M | -260.8M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | 74.1M | 167.9M | 143.0M | 40.2M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 3.8M | 600.0K | 0.00 | 0.00 | ||
| Net Cash Flow - Financing | 70.3M | 167.3M | 143.0M | 40.2M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | -- | -- | -- |
| Net Change In Cash | 66.0M | 197.2M | 67.6M | -281.8M | ||
